KIT and ovarian carcinoma: We have observed upregulation of CD36 in SKOV-3-R, a cisplatin-selected subline of SKOV-3 ovarian cancer cells, a multi-drug resistant subline and which, unlike the parental line, forms spheres in stem cell medium and expresses ALDH1A, CD117 and CD44 [47].